Alger Concentrated Equity ETF Outperformed Russell 1000 Growth in Q2 2026

A single quarter of index-beating returns in a concentrated portfolio warrants scrutiny of whether outperformance reflects strategy durability or favorable sector timing.

The Alger Concentrated Equity ETF (ticker: CNEQ) outperformed the Russell 1000 Growth Index during the second quarter of 2026, according to the fund's Q2 2026 Commentary published by Alger and excerpted on Seeking Alpha. The fund reported a net asset value of $41.07 and a closing price of $41.27 as of June 30, 2026, implying the shares traded at a modest premium to NAV on that date, per the same disclosure.

The fund carries a gross expense ratio of 0.66 percent, according to the Q2 2026 fund snapshot included in the Alger commentary. The ETF launched on April 4, 2024, giving it approximately two years of operating history as of the reporting date. The commentary named Nebius Group as one holding, though a complete portfolio breakdown was not reproduced in the excerpted segment reviewed for this article.

The Russell 1000 Growth Index, maintained by FTSE Russell, serves as the fund's stated benchmark. Concentrated equity strategies, by construction, hold fewer positions than diversified funds, which can amplify both gains and losses relative to a broad index in any given quarter. Whether the Q2 outperformance was driven by stock selection, sector allocation, or a small number of outsized individual holdings is not fully determinable from the excerpted commentary alone. A complete attribution analysis would require the full quarterly report and position-level data.

CNEQ trades on a US exchange and is registered under US securities law, placing it within the regulatory jurisdiction of the Securities and Exchange Commission. Investors seeking to evaluate the sustainability of the Q2 result would need to review full portfolio holdings disclosed in the fund's SEC filings, including its most recent Form N-PORT, which funds are required to file monthly with a 60-day lag.